JP2019501863A5 - - Google Patents

Download PDF

Info

Publication number
JP2019501863A5
JP2019501863A5 JP2018516828A JP2018516828A JP2019501863A5 JP 2019501863 A5 JP2019501863 A5 JP 2019501863A5 JP 2018516828 A JP2018516828 A JP 2018516828A JP 2018516828 A JP2018516828 A JP 2018516828A JP 2019501863 A5 JP2019501863 A5 JP 2019501863A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
binding moiety
substituted
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018516828A
Other languages
English (en)
Japanese (ja)
Other versions
JP7411326B2 (ja
JP2019501863A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/054691 external-priority patent/WO2017059207A1/en
Publication of JP2019501863A publication Critical patent/JP2019501863A/ja
Publication of JP2019501863A5 publication Critical patent/JP2019501863A5/ja
Priority to JP2023000295A priority Critical patent/JP7812813B2/ja
Application granted granted Critical
Publication of JP7411326B2 publication Critical patent/JP7411326B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018516828A 2015-10-01 2016-09-30 タンパク質-タンパク質インターフェースを分析するための方法および試薬 Active JP7411326B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023000295A JP7812813B2 (ja) 2015-10-01 2023-01-04 タンパク質-タンパク質インターフェースを分析するための方法および試薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562235896P 2015-10-01 2015-10-01
US62/235,896 2015-10-01
PCT/US2016/054691 WO2017059207A1 (en) 2015-10-01 2016-09-30 Methods and reagents for analyzing protein-protein interfaces

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023000295A Division JP7812813B2 (ja) 2015-10-01 2023-01-04 タンパク質-タンパク質インターフェースを分析するための方法および試薬

Publications (3)

Publication Number Publication Date
JP2019501863A JP2019501863A (ja) 2019-01-24
JP2019501863A5 true JP2019501863A5 (https=) 2019-11-21
JP7411326B2 JP7411326B2 (ja) 2024-01-11

Family

ID=58427956

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018516828A Active JP7411326B2 (ja) 2015-10-01 2016-09-30 タンパク質-タンパク質インターフェースを分析するための方法および試薬
JP2023000295A Active JP7812813B2 (ja) 2015-10-01 2023-01-04 タンパク質-タンパク質インターフェースを分析するための方法および試薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023000295A Active JP7812813B2 (ja) 2015-10-01 2023-01-04 タンパク質-タンパク質インターフェースを分析するための方法および試薬

Country Status (6)

Country Link
US (5) US9989535B2 (https=)
EP (2) EP4242304A3 (https=)
JP (2) JP7411326B2 (https=)
AU (3) AU2016329064B2 (https=)
CA (1) CA3000822A1 (https=)
WO (1) WO2017059207A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
US10533016B2 (en) 2015-01-09 2020-01-14 Revolution Medicines, Inc. Compounds that participate in cooperative binding and uses thereof
WO2017059207A1 (en) 2015-10-01 2017-04-06 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
US11066416B2 (en) 2016-02-04 2021-07-20 The Johns Hopkins University Rapafucin derivative compounds and methods of use thereof
US10774110B2 (en) 2016-02-04 2020-09-15 The Johns Hopkins University Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof
CA3013783A1 (en) 2016-02-04 2017-08-10 The Johns Hopkins University Rapaglutins, novel inhibitors of glut and use thereof
CA3020594A1 (en) 2016-04-12 2017-10-19 Warp Drive Bio, Inc. Compositions and methods for the production of compounds
KR102598895B1 (ko) 2016-07-12 2023-11-07 레볼루션 메디슨즈, 인크. 다른자리 입체성 shp2 억제제로서의 2,5-이치환 3-메틸 피라진 및 2,5,6-3치환 3-메틸 피라진
MX2019008695A (es) 2017-01-23 2019-09-11 Revolution Medicines Inc Compuestos biciclicos como inhibidores alostericos de shp2.
MX2019008696A (es) 2017-01-23 2019-09-13 Revolution Medicines Inc Compuestos de piridina como inhibidores de shp2 alostericos.
KR20240093922A (ko) * 2017-04-05 2024-06-24 레볼루션 메디슨즈, 인크. 단백질-단백질 계면을 분석하기 위한 방법 및 시약
AU2018248417A1 (en) * 2017-04-05 2019-11-14 Revolution Medicines, Inc. Compounds that participate in cooperative binding and uses thereof
CA3074690A1 (en) 2017-09-07 2019-03-14 Revolution Medicines, Inc. Shp2 inhibitor compositions and methods for treating cancer
MX2020003579A (es) 2017-10-12 2020-07-22 Revolution Medicines Inc Compuestos de piridina, pirazina, y triazina como inhibidores de shp2 alostericos.
BR112020009757A2 (pt) 2017-12-15 2020-11-03 Revolution Medicines, Inc. compostos policíclicos como inibidores alostéricos de shp2
US11802132B2 (en) * 2018-02-23 2023-10-31 Dana-Farber Cancer Institute, Inc. Small molecules for inducing selective protein degradation and uses thereof
CN120699039A (zh) 2019-11-04 2025-09-26 锐新医药公司 Ras抑制剂
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
US20250388598A1 (en) * 2019-11-04 2025-12-25 Revolution Medicines, Inc. Ras inhibitors
WO2021091956A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
EP4055365B1 (en) * 2019-11-08 2026-01-21 NanoTemper Technologies GmbH Characterization of particles in solution
CN111118046B (zh) * 2020-01-16 2022-02-22 中国人民解放军军事科学院军事医学研究院 一种能够调控MSCs成脂肪分化能力的基因及其衍生产品
GB202007106D0 (en) * 2020-05-14 2020-07-01 Ucl Business Plc Cyclosporine analogues
MX2023003060A (es) 2020-09-15 2023-04-05 Revolution Medicines Inc Derivados indolicos como inhibidores de ras en el tratamiento del cancer.
AU2022268962A1 (en) 2021-05-05 2023-12-14 Revolution Medicines, Inc. Ras inhibitors for the treatment of cancer
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras
CN119661684B (zh) * 2024-10-21 2025-11-25 山东大学 一种高抗炎活性的脂联素突变体及其制备方法与应用

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92501T1 (de) 1984-10-04 1993-08-15 Sandoz Ag Monoklonale antikoerper gegen zyklosporine.
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
DK0393934T3 (da) 1989-04-15 1994-11-21 Nippon Chemiphar Co Nye peptider samt antidemensmidler indeholdende disse peptider
US5137877B1 (en) * 1990-05-14 1996-01-30 Bristol Myers Squibb Co Bifunctional linking compounds conjugates and methods for their production
DK0562853T3 (da) 1992-03-27 1996-07-01 American Home Prod 29-Demethoxyrapamycin til fremkaldelse af immunsuppression
ES2164713T3 (es) 1993-09-20 2002-03-01 Univ Leland Stanford Junior Produccion recombinante de nuevos poliquetidos.
IL112873A (en) 1994-03-08 2005-03-20 Wyeth Corp Rapamycin-fkbp12 binding proteins, their isolation and their use
GB9410142D0 (en) 1994-05-20 1994-07-06 Univ Warwick Carbapenems
GB9524630D0 (en) 1994-12-24 1996-01-31 Zeneca Ltd Chemical compounds
US5624677A (en) 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US6124453A (en) * 1995-07-04 2000-09-26 Novartis Ag Macrolides
SE9603465D0 (sv) 1996-09-23 1996-09-23 Astra Ab New compounds
US6902913B2 (en) 1997-04-30 2005-06-07 Kosan Biosciences, Inc. Recombinant narbonolide polyketide synthase
US6153383A (en) 1997-12-09 2000-11-28 Verdine; Gregory L. Synthetic transcriptional modulators and uses thereof
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
NZ510819A (en) 1998-10-02 2004-03-26 Kosan Biosciences Inc Polyketide synthase enzymes and recombinant DNA constructs therefor
US6686454B1 (en) * 1998-10-09 2004-02-03 Isotechnika, Inc. Antibodies to specific regions of cyclosporine related compounds
GB9927191D0 (en) 1999-11-17 2000-01-12 Angeletti P Ist Richerche Bio Methods and means for regulation of gene expression
US7220552B1 (en) * 1999-11-19 2007-05-22 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and their use in the disruption of protein-protein interactions
AU1776501A (en) 1999-11-19 2001-05-30 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and their use in the disruption of protein-protein interactions
TR200200767T1 (tr) 2000-05-23 2002-09-23 Vertex Pharmaceuticals Incorporated Kaspaz engelleyiciler ve kullanımları
US7176037B2 (en) 2000-07-13 2007-02-13 The Scripps Research Institute Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
US20030153053A1 (en) 2001-08-06 2003-08-14 Ralph Reid Methods for altering polyketide synthase genes
US6809077B2 (en) * 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
US6987090B2 (en) * 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
WO2004041279A1 (en) * 2002-10-30 2004-05-21 Merck & Co., Inc. Gamma-aminoamide modulators of chemokine receptor activity
US7012065B2 (en) * 2003-02-07 2006-03-14 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of immune disorders
US8653238B2 (en) * 2006-02-27 2014-02-18 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for transport of molecules with enhanced release properties across biological barriers
US20070203168A1 (en) 2006-02-28 2007-08-30 Zhao Jonathon Z Isomers of rapamycin and 42-Epi-rapamycin, methods of making and using the same
US7601852B2 (en) 2006-05-11 2009-10-13 Kosan Biosciences Incorporated Macrocyclic kinase inhibitors
GB0805363D0 (en) 2008-03-20 2008-04-30 Sinvent As Novel NRPS-PKS gene cluster and its manipulation and utility
WO2010031185A1 (en) 2008-09-19 2010-03-25 Protox Therapeutics Inc. Treating cancer stem cells using targeted cargo proteins
EP2342335B1 (en) 2008-09-24 2015-09-16 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences Novel gene cluster
WO2010088573A1 (en) 2009-01-30 2010-08-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis c infection
JP2012532929A (ja) * 2009-07-13 2012-12-20 プレジデント アンド フェロウズ オブ ハーバード カレッジ 二機能性のステープリングされたポリペプチドおよびそれらの使用
EP2456777A2 (en) 2009-07-24 2012-05-30 Université Henri Poincaré - Nancy 1 Stambomycin and derivatives, their production and their use as drugs
US20130072439A1 (en) 2009-09-22 2013-03-21 Huw M. Nash Peptidomimetic macrocycles
US20120208720A1 (en) 2009-10-22 2012-08-16 Kenji Kashiwagi Rapid display method in translational synthesis of peptide
EP2646440A4 (en) 2010-11-30 2014-06-18 Univ Johns Hopkins CYCLIC HYBRID LIBRARIES AND SCREENS FOR THIS
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
AU2012257513B2 (en) 2011-05-19 2017-05-11 Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncológicas Carlos III (F.S.P. CNIO) Macrocyclic compounds as protein kinase inhibitors
WO2012174489A2 (en) 2011-06-15 2012-12-20 The Ohio State University Small molecule composite surfaces as inhibitors of protein-protein interactions
DE102011111991A1 (de) * 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
WO2013052393A1 (en) 2011-10-05 2013-04-11 Merck Sharp & Dohme Corp. 3-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
AR091279A1 (es) 2012-06-08 2015-01-21 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
PL2872157T3 (pl) 2012-07-12 2020-07-13 Hangzhou Dac Biotech Co., Ltd Koniugaty wiążących komórkę cząsteczek ze środkami cytotoksycznymi
US10131682B2 (en) * 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
EP2806274A1 (en) 2013-05-24 2014-11-26 AIT Austrian Institute of Technology GmbH Lung cancer diagnostic method and means
US10233431B2 (en) 2014-02-26 2019-03-19 The Regents Of The University Of California Producing 3-hydroxycarboxylic acid and ketone using polyketide synthases
US20170067894A1 (en) 2014-03-03 2017-03-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method and device for detection of pseudomonas aeruginosa
US10533016B2 (en) 2015-01-09 2020-01-14 Revolution Medicines, Inc. Compounds that participate in cooperative binding and uses thereof
TW201629069A (zh) 2015-01-09 2016-08-16 霍普驅動生物科技股份有限公司 參與協同結合之化合物及其用途
US10077289B2 (en) * 2015-03-31 2018-09-18 Allergan, Inc. Cyclosporins modified on the MeBmt sidechain by heterocyclic rings
WO2017059207A1 (en) 2015-10-01 2017-04-06 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
JP2020501519A (ja) 2016-10-28 2020-01-23 ギンゴー バイオワークス, インコーポレイテッド 化合物の生産のための組成物および方法

Similar Documents

Publication Publication Date Title
JP2019501863A5 (https=)
JP2020520988A5 (https=)
JP2023052201A5 (https=)
Sumerlin Proteins as initiators of controlled radical polymerization: grafting-from via ATRP and RAFT
Toure et al. Small‐molecule PROTACS: new approaches to protein degradation
Chen et al. Understanding the fascinating origins of CO2 adsorption and dynamics in MOFs
Heredia et al. Synthesis of heterotelechelic polymers for conjugation of two different proteins
Anastasaki et al. Cu (0)-mediated living radical polymerization: a versatile tool for materials synthesis
Vial et al. Controlling the biological effects of spermine using a synthetic receptor
EP3839049A3 (en) Antibodies, variable domains & chains tailored for human use
Eaton et al. γ-aminobutyric acid type A α4, β2, and δ subunits assemble to produce more than one functionally distinct receptor type
JP2017532962A5 (https=)
JP2017502690A5 (https=)
WO2015130846A3 (en) Compositions and methods for the site-specific modification of polypeptides
ATE507240T1 (de) Materialien und verfahren für wachstumsfaktorbindende konstrukte
RU2016124163A (ru) Сконструированные высокоаффинные t-клеточные рецепторы человека
EA201390611A1 (ru) Мультиспецифические антигенсвязывающие белки, направленные на hgf
JP2009507035A5 (https=)
WO2012085069A3 (en) Detection of a polypeptide dimer by a bivalent binding agent
JP2015506961A5 (https=)
JP2015536446A5 (https=)
WO2011132842A3 (ko) 표면에 콜라겐이 결합된 이상인산칼슘 골대체재의 제조방법 및 그 방법에 의해 제조된 골대체재
WO2012012531A3 (en) Compositions and methods featuring il-6 and il-21 antagonists
AR076598A1 (es) Derivados espirociclicos de furan y tiofuran, procesos de preparacion y composiciones pesticidas
TR200809452T1 (tr) Süspansiyon polimerizasyonu yoluyla vinil klorür bazlı polimer üretilmesine ilişkin yöntem.